266 related articles for article (PubMed ID: 14716819)
1. Construction of a targeting adenoviral vector carrying AFP promoter for expressing EGFP gene in AFP-producing hepatocarcinoma cell.
Shi YJ; Gong JP; Liu CA; Li XH; Mei Y; Mi C; Huo YY
World J Gastroenterol; 2004 Jan; 10(2):186-9. PubMed ID: 14716819
[TBL] [Abstract][Full Text] [Related]
2. Construction of a regulable gene therapy vector targeting for hepatocellular carcinoma.
Lu SY; Sui YF; Li ZS; Pan CE; Ye J; Wang WY
World J Gastroenterol; 2003 Apr; 9(4):688-91. PubMed ID: 12679911
[TBL] [Abstract][Full Text] [Related]
3. [Construction of a plasmid vector of fused protein genes driven by human insulin-like growth factor II P3 promoter].
Zhou HK; Yang DH; Tang SH; Huang W; Lu XH
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):106-10. PubMed ID: 16620715
[TBL] [Abstract][Full Text] [Related]
4. [Construction of a hepatoma-targeting vector of adeno-associated virus containing human alpha-fetoprotein promoter and wild p53 gene in gene therapy of liver cancer].
Cheng J; Leng X; Peng J
Zhonghua Yi Xue Za Zhi; 2000 Jun; 80(6):461-3. PubMed ID: 11798803
[TBL] [Abstract][Full Text] [Related]
5. [Establishment of AFP promoter operated murine IL-1beta recombinant vector and its expression in H22 cells].
Li QC; Liang SJ; Wang XJ; Liu YY; Wang HQ; Zhang SH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Jul; 25(7):603-5. PubMed ID: 19737477
[TBL] [Abstract][Full Text] [Related]
6. [Construction and study of replication-defective adenovirus targeting hepatocarcinoma].
Xu DY; Du ZY; Wang Y; Chen HH; Xu YJ; Lu YL
Ai Zheng; 2006 Jul; 25(7):798-804. PubMed ID: 16831267
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene.
Kanai F; Shiratori Y; Yoshida Y; Wakimoto H; Hamada H; Kanegae Y; Saito I; Nakabayashi H; Tamaoki T; Tanaka T; Lan KH; Kato N; Shiina S; Omata M
Hepatology; 1996 Jun; 23(6):1359-68. PubMed ID: 8675152
[TBL] [Abstract][Full Text] [Related]
8. In vivo bioluminescent imaging of α-fetoprotein-producing hepatocellular carcinoma in the diethylnitrosamine-treated mouse using recombinant adenoviral vector.
Kim KI; Park JH; Lee YJ; Lee TS; Park JJ; Song I; Nahm SS; Cheon GJ; Lim SM; Chung JK; Kang JH
J Gene Med; 2012 Aug; 14(8):513-20. PubMed ID: 22761128
[TBL] [Abstract][Full Text] [Related]
9. Robust prostate-specific expression for targeted gene therapy based on the human kallikrein 2 promoter.
Xie X; Zhao X; Liu Y; Young CY; Tindall DJ; Slawin KM; Spencer DM
Hum Gene Ther; 2001 Mar; 12(5):549-61. PubMed ID: 11268287
[TBL] [Abstract][Full Text] [Related]
10. [Impact of AFP promoter on the expressions of GFP in tumor cells].
Mao CQ; Huang CZ; Yang SD; Zhao M; Fan YX; Xu F; Du F
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Oct; 23(5):495-8. PubMed ID: 12905870
[TBL] [Abstract][Full Text] [Related]
11. [Expression and localization of strong epitope hAFP(542-550); on eukaryotic cytoplasmic membrane].
Yang DY; Li CH; Lan F; Zhang YQ; Lu FG; Yang ZR; Huang LQ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Jul; 25(7):592-5, 599. PubMed ID: 19737475
[TBL] [Abstract][Full Text] [Related]
12. Effect of recombinant plasmid pEGFP-AFP-hTNF on liver cancer cells (HepG2 Cells) in vitro when delivered by PEG-PEI/Fe₃O₄ nanomagnetic fluid.
Zhuang B; Zhang Y; Peng J; Zhang H; Hu T; Zeng J; Li Y
J Formos Med Assoc; 2011 May; 110(5):326-35. PubMed ID: 21621154
[TBL] [Abstract][Full Text] [Related]
13. E1B-55K-deleted adenovirus expressing E1A-13S by AFP-enhancer/promoter is capable of highly specific replication in AFP-producing hepatocellular carcinoma and eradication of established tumor.
Takahashi M; Sato T; Sagawa T; Lu Y; Sato Y; Iyama S; Yamada Y; Fukaura J; Takahashi S; Miyanishi K; Yamashita T; Sasaki K; Kogawa K; Hamada H; Kato J; Niitsu Y
Mol Ther; 2002 May; 5(5 Pt 1):627-34. PubMed ID: 11991754
[TBL] [Abstract][Full Text] [Related]
14. [Construction of hepatoma-targeting recombinant co-expression adenovirus vector of SEA and CD80 and identification of its expression].
Si SY; Sui YF; Hu PZ; Zhang XM; Ge W; Li ZS; Huang Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Sep; 22(5):613-6. PubMed ID: 16948908
[TBL] [Abstract][Full Text] [Related]
15. In vivo therapy of hepatocellular carcinoma with a tumor-specific adenoviral vector expressing interleukin-2.
Bui LA; Butterfield LH; Kim JY; Ribas A; Seu P; Lau R; Glaspy JA; McBride WH; Economou JS
Hum Gene Ther; 1997 Dec; 8(18):2173-82. PubMed ID: 9449371
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter.
Ido A; Nakata K; Kato Y; Nakao K; Murata K; Fujita M; Ishii N; Tamaoki T; Shiku H; Nagataki S
Cancer Res; 1995 Jul; 55(14):3105-9. PubMed ID: 7541712
[TBL] [Abstract][Full Text] [Related]
17. A new membrane re-anchored protein originating from GPC3 against hepatoma cells HepG2.
Yang D; Yang J; Lu F; Li C; Yang J; Liang J
Mol Med Rep; 2011; 4(6):1067-73. PubMed ID: 21904776
[TBL] [Abstract][Full Text] [Related]
18. Targeting gene therapy for hepatocarcinoma cells with the E. coli purine nucleoside phosphorylase suicide gene system directed by a chimeric alpha-fetoprotein promoter.
Cai X; Zhou J; Chang Y; Sun X; Li P; Lin J
Cancer Lett; 2008 Jun; 264(1):71-82. PubMed ID: 18407409
[TBL] [Abstract][Full Text] [Related]
19. In vivo gene delivery and visualization of corneal stromal cells using an adenoviral vector and keratocyte-specific promoter.
Carlson EC; Liu CY; Yang X; Gregory M; Ksander B; Drazba J; Perez VL
Invest Ophthalmol Vis Sci; 2004 Jul; 45(7):2194-200. PubMed ID: 15223795
[TBL] [Abstract][Full Text] [Related]
20. Insulation from viral transcriptional regulatory elements enables improvement to hepatoma-specific gene expression from adenovirus vectors.
Ye X; Liang M; Meng X; Ren X; Chen H; Li ZY; Ni S; Lieber A; Hu F
Biochem Biophys Res Commun; 2003 Aug; 307(4):759-64. PubMed ID: 12878174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
